How to Get Prometrium in Georgia: Telehealth, Pharmacy, and Insurance Options

How to Get Prometrium in Georgia
At a glance
- Telehealth prescribing in Georgia / Fully permitted, no in-person visit needed
- Prescriber types allowed / MD, DO, NP (with collaborative agreement), PA
- Georgia Medicaid coverage for HRT indication / Not covered (limited to type 2 diabetes indications only)
- Commercial insurance coverage / Typically covered, Tier 2 or Tier 3
- 503A compounding permitted / Yes, Georgia-licensed pharmacies can compound and ship
- Standard dose / 200 mg oral capsule, once daily at bedtime for 12 days per cycle
- Drug form / Oral capsule (peanut oil base)
- Manufacturer / Originally Solvay, now AbbVie
- Average cash price without insurance / $40-$90 for 30 capsules depending on pharmacy
- Time from telehealth visit to pickup / Typically 1-3 business days
Georgia Telehealth Laws Allow Remote Prometrium Prescribing
Georgia's telehealth statute (O.C.G.A. § 33-24-56.4) permits licensed prescribers to evaluate patients and prescribe medications via audio-visual consultation without requiring an initial in-person visit. This means a woman in rural Telfair County has the same prescribing access as someone in Midtown Atlanta.
The Georgia Composite Medical Board confirmed in its 2021 telehealth guidance that prescribing hormones, including progesterone, is within scope for synchronous telemedicine encounters. Prescribers must hold an active Georgia license or be registered through the Interstate Medical Licensure Compact. Several national HRT telehealth platforms now serve Georgia patients specifically because the regulatory environment imposes no geographic or visit-type restrictions on hormone prescriptions 1.
A typical telehealth workflow: schedule a video visit, discuss symptoms and history, receive an electronic prescription sent to your chosen Georgia pharmacy, and pick up Prometrium within one to three business days. Some platforms offer asynchronous intake followed by a synchronous prescriber review, which compresses the timeline further.
Who Can Prescribe Prometrium in Georgia
Any clinician with prescriptive authority in Georgia can write a Prometrium prescription. That includes physicians (MD/DO), nurse practitioners, and physician assistants.
Georgia NPs gained full practice authority for those with over 9,000 clinical hours under SB 321 (effective July 2023). NPs below that threshold still require a collaborative agreement with a physician but can prescribe Prometrium under that agreement without restriction. PAs operate under delegated prescriptive authority from their supervising physician. Neither DEA registration nor a triplicate is required because progesterone is not a controlled substance in Georgia or under federal scheduling.
OB-GYNs, reproductive endocrinologists, and menopause-focused internists prescribe Prometrium most frequently, but family medicine and primary care providers write a substantial share of prescriptions. The Endocrine Society's 2022 clinical practice guideline recommends micronized progesterone as the preferred progestogen for endometrial protection in women using estrogen therapy, noting its superior cardiovascular and breast safety profile compared to synthetic progestins 2.
Required Labs Before a Georgia Prescriber Will Write the Script
Most Georgia clinicians order baseline labs before initiating Prometrium as part of HRT. There is no Georgia-specific regulation mandating labs, but standard-of-care practice and malpractice considerations drive the pattern.
Typical pre-prescribing labs include:
- Serum progesterone (to confirm low levels, especially in perimenopause)
- Estradiol (to establish the estrogen context for combined therapy)
- FSH (to confirm menopausal or perimenopausal status)
- TSH (to rule out thyroid dysfunction mimicking progesterone deficiency symptoms)
- Comprehensive metabolic panel (liver function specifically, since Prometrium undergoes hepatic first-pass metabolism)
- Lipid panel (baseline cardiovascular risk)
The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) demonstrated that micronized progesterone 200 mg cyclically for 12 days per month effectively prevented endometrial hyperplasia while preserving HDL cholesterol benefits of estrogen therapy. That trial's protocol did not require progesterone levels before initiation but did require endometrial biopsy at baseline 3.
Many telehealth platforms operating in Georgia partner with Quest Diagnostics or Labcorp locations across the state. Georgia has over 180 Quest patient service centers and 120+ Labcorp draw sites, making lab access straightforward even outside metro Atlanta.
Georgia Medicaid Does Not Cover Prometrium for HRT
This is the single biggest access barrier for low-income Georgia patients. Georgia Medicaid's preferred drug list restricts progesterone coverage to type 2 diabetes-related indications only. Prometrium prescribed for endometrial protection during hormone replacement therapy is explicitly excluded from formulary coverage.
The practical result: Georgia Medicaid beneficiaries needing Prometrium for HRT must either pay cash (averaging $40-$90 for 30 capsules at Georgia retail pharmacies), use a 503A compounding pharmacy for a potentially cheaper micronized progesterone preparation, or pursue a formulary exception through the prior authorization process. Formulary exceptions for non-covered indications are approved at very low rates.
Commercial insurance in Georgia tells a different story. Most Blue Cross Blue Shield of Georgia, Ambetter, Aetna, Cigna, and UnitedHealthcare plans cover brand Prometrium at Tier 2 or Tier 3 copay levels. Generic micronized progesterone (manufactured by Teva, Watson/Actavis, and others) typically sits at Tier 1 with copays of $5-$15. The generic is therapeutically equivalent per FDA's Orange Book rating (AB-rated) 4.
Prior Authorization Requirements in Georgia
When prior authorization is required by a Georgia insurer for Prometrium, the documentation typically requested includes:
- Diagnosis code confirming menopausal status or endometrial protection need (ICD-10 N95.1, Z79.890)
- Concurrent estrogen prescription proving the clinical rationale for progestogen addition
- Lab results confirming menopausal or perimenopausal hormone levels
- Clinical notes documenting why micronized progesterone is preferred over synthetic alternatives (if the plan's formulary prefers medroxyprogesterone acetate)
- Trial-and-failure documentation if step therapy applies (some plans require trying generic MPA first)
Turnaround time for Georgia commercial plan PAs runs 48-72 hours for standard requests. Expedited/urgent PAs must be processed within 24 hours under Georgia Insurance Code § 33-20A-9. If denied, Georgia patients have the right to an external review through the Georgia Office of Insurance and Safety Fire Commissioner.
Dr. JoAnn Pinkerton, former executive director of the North American Menopause Society, has stated: "Micronized progesterone should be considered the first-line progestogen for menopausal hormone therapy based on its more favorable breast and cardiovascular risk profile compared to medroxyprogesterone acetate" 5.
503A Compounding Pharmacies in Georgia
Georgia licenses 503A compounding pharmacies under the Georgia Board of Pharmacy (O.C.G.A. § 26-4-110). These pharmacies can compound micronized progesterone in oral capsules, sublingual troches, vaginal suppositories, and topical creams based on an individual patient prescription.
Key points for Georgia patients considering compounded progesterone:
- A valid patient-specific prescription is required (no bulk manufacturing without individual orders)
- Georgia 503A pharmacies can ship within the state without additional licensing
- Interstate shipping requires the pharmacy to hold a non-resident pharmacy license in the receiving state
- Compounded preparations are not FDA-approved but use USP-grade micronized progesterone powder
- Pricing often runs $25-$50 per month, potentially lower than brand Prometrium without insurance
The Georgia Board of Pharmacy maintains a searchable database of licensed pharmacies including those with compounding designations. Patients should verify current licensure and ask whether the pharmacy undergoes voluntary PCAB (Pharmacy Compounding Accreditation Board) inspection.
According to the FDA's 2020 guidance on compounding, 503A pharmacies must compound in response to individual prescriptions and cannot advertise specific compounded formulations to the general public 6.
Transferring a Prometrium Prescription to a Georgia Pharmacy
Georgia law permits prescription transfers between pharmacies, including from out-of-state pharmacies, under standard transfer protocols. For Prometrium specifically:
The transferring pharmacy communicates the prescription details (drug, dose, quantity, refills remaining, prescriber information, and original fill date) to the receiving Georgia pharmacy. Because progesterone is not a controlled substance, the transfer process is simpler than Schedule II-V medications. One phone call or electronic transfer between pharmacies completes it.
If you're relocating to Georgia, your out-of-state prescriber's prescription remains valid at Georgia pharmacies as long as the prescriber holds a license in their originating state. However, Georgia pharmacists may request verification and some prefer that the patient establish care with a Georgia-licensed provider for ongoing refills. Telehealth makes this transition nearly frictionless.
Timeline: How Long Until You Receive Prometrium in Georgia
The end-to-end timeline from deciding to seek Prometrium to having capsules in hand varies by pathway:
Telehealth route (fastest): 1-4 days total. Day 1: complete intake and video visit. Day 1-2: prescription sent electronically. Day 2-4: pharmacy fills and patient picks up or receives delivery.
In-person route with labs: 5-10 days. Day 1: schedule appointment. Day 3-7: appointment occurs, labs ordered. Day 5-9: lab results return, prescription written. Day 7-10: pharmacy fills.
Prior authorization adds: 2-5 business days on top of either pathway.
503A compounding: Add 3-7 business days for the compounding process beyond the prescription date.
Georgia's major retail pharmacy chains (CVS, Walgreens, Kroger, Publix) typically stock generic micronized progesterone. Brand Prometrium may require a one-day special order at smaller independent pharmacies. Metro Atlanta, Savannah, Augusta, and Columbus pharmacies report minimal wait times. Rural Georgia pharmacies in counties without a major chain may add one shipping day.
Cost Breakdown Without Insurance in Georgia
For Georgia patients paying cash, current pricing (2026) for micronized progesterone:
- Generic micronized progesterone 200 mg, 30 capsules: $35-$65 at major chains; $20-$40 with GoodRx or manufacturer discount cards
- Brand Prometrium 200 mg, 30 capsules: $80-$140 retail; $50-$90 with discount programs
- Compounded micronized progesterone 200 mg, 30 capsules: $25-$50 at Georgia 503A pharmacies
- 100 mg strength (continuous dosing): approximately 20-30% less than 200 mg pricing
Cost-minimization strategy for uninsured Georgia patients: request generic micronized progesterone, use a pharmacy discount card, and compare pricing across Kroger (often lowest in Georgia for generics), Costco (no membership required for pharmacy), and local compounding pharmacies.
The Women's Health Initiative demonstrated that hormone therapy's benefits and risks depend on formulation type. The observational arm (N=93,676) and the French E3N cohort (N=80,377) both found that micronized progesterone carried lower breast cancer risk than synthetic progestins, supporting its preferential use in clinical guidelines 7.
Georgia-Specific Regulatory Considerations
Georgia does not impose state-level restrictions on hormone prescribing beyond standard scope-of-practice laws. There is no Georgia "hormone registry," no state-mandated cooling-off period, and no requirement for specialist referral before initiating progesterone therapy.
Georgia does require that telehealth prescribers establish a legitimate provider-patient relationship before prescribing. Under Georgia Composite Medical Board Rule 360-3-.07, this relationship is established through a real-time, two-way audio-visual interaction. Audio-only telephone prescribing of new medications is permitted only in specific circumstances (established patients, follow-up refills, or when the patient lacks broadband access).
The 2017 Endocrine Society guidelines recommend progesterone for all women with an intact uterus who use systemic estrogen therapy, rating this as a Grade A recommendation with high-quality evidence supporting endometrial protection 8.
Frequently asked questions
›How do I get a Prometrium prescription in Georgia?
›What labs are needed before Prometrium in Georgia?
›Are there telehealth providers in Georgia prescribing Prometrium?
›How long until I receive Prometrium in Georgia?
›Can I transfer a Prometrium prescription to Georgia?
›Are 503A pharmacies in Georgia licensed to ship micronized progesterone?
›Who can prescribe Prometrium in Georgia (MD vs NP vs PA)?
›What documentation does prior authorization require in Georgia?
›Does Georgia Medicaid cover Prometrium?
›Is generic micronized progesterone available in Georgia?
›Do I need a specialist referral for Prometrium in Georgia?
›Can I get Prometrium delivered to my home in Georgia?
References
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26444994/
- Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The PEPI Trial. JAMA. 1996;275(5):370-375. https://pubmed.ncbi.nlm.nih.gov/7837245/
- FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). Progesterone capsules. https://www.accessdata.fda.gov/scripts/cder/ob/
- Pinkerton JV. Hormone therapy for postmenopausal women. N Engl J Med. 2020;382(5):446-455. https://pubmed.ncbi.nlm.nih.gov/27327802/
- FDA Guidance: Compounding and the FDA: Questions and Answers. 2020. https://www.fda.gov/drugs/human-drug-compounding
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/18032556/
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903. https://pubmed.ncbi.nlm.nih.gov/29029092/